Modification of risk, but not survival of esophageal cancer patients by esophageal cancer-related gene 1 Arg290Gln polymorphism: A case-control study and meta-analysis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 11, 2013, Pages 1717-1724

  Umar, Meenakshi ^a   Upadhyay, Rohit ^a   Kumar, Shaleen ^a   Ghoshal, Uday Chand ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

ECRG1; Esophageal cancer; Prognosis; Susceptibility

Indexed keywords

ARGININE; GLUTAMINE;

ADULT; AGED; ALLELE; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL CANCER RELATED GENE 1; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INDIAN; LOW RISK POPULATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR LOCALIZATION; TUMOR SUPPRESSOR GENE;

ECRG1; ESOPHAGEAL CANCER; PROGNOSIS; SUSCEPTIBILITY;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HUMANS; INDIA; KAPLAN-MEIER ESTIMATE; MEMBRANE PROTEINS; META-ANALYSIS AS TOPIC; POLYMORPHISM, GENETIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK; RISK FACTORS; SERINE PROTEASES; SURVIVAL RATE;

EID: 84897672026     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12335     Document Type: Article

References (40)

1. Takiar R, Nadayil D, Nandakumar A. Projections of number of cancer cases in India (2010-2020) by cancer groups. Asian Pac. J. Cancer Prev. 2010; 11: 1045-1049.
2. McCabe ML, Dlamini Z. The molecular mechanisms of oesophageal cancer. Int. Immunopharmacol. 2005; 5: 1113-1130.
3. Vallbohmer D, Brabender J, Metzger R, Holscher AH. Genetics in the pathogenesis of esophageal cancer: possible predictive and prognostic factors. J. Gastrointest. Surg. 2010; 14 (Suppl. 1): S75-80.
4. Yang ZQ, Imoto I, Fukuda Y etal. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res. 2000; 60: 4735-4739.
5. Luo A, Kong J, Hu G etal. Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 2004; 23: 1291-1299.
6. Su T, Liu H, Lu S. Cloning and identification of cDNA fragments related to human esophageal cancer. Zhonghua Zhong Liu Za Zhi. 1998; 20: 254-257.
7. Li Y, Zhang X, Huang G etal. Identification of a novel polymorphism Arg290Gln of esophageal cancer related gene 1 (ECRG1) and its related risk to esophageal squamous cell carcinoma. Carcinogenesis 2006; 27: 798-802.
8. Netzel-Arnett S, Hooper JD, Szabo R etal. Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev. 2003; 22: 237-258.
9. Perona JJ, Craik CS. Structural basis of substrate specificity in the serine proteases. Protein Sci. 1995; 4: 337-360.
10. Liu H, Su T, Wang Y, Zhao X, Zhou C, Lu S. Cloning of new related to human esophageal carcinoma and its expression in the human esophageal carcinoma. Proc. Am. Assoc. Cancer Res. 1999; 40: 239.
11. Zhao N, Huang G, Guo L, Lu SH. ECRG1, a novel candidate of tumor suppressor gene in the esophageal carcinoma, triggers a senescent program in NIH3T3 cells. Exp. Biol. Med. (Maywood) 2006; 231: 84-90.
12. Yueying W, Jianbo W, Hailin L, Huaijing T, Liping G, Shih-Hsin L. ECRG1, a novel esophageal gene, cloned and identified from human esophagus and its inhibition effect on tumors. Carcinogenesis 2008; 29: 157-160.
13. Zhao N, Wang J, Cui Y, Guo L, Lu SH. Induction of G1 cell cycle arrest and P15INK4b expression by ECRG1 through interaction with Miz-1. J. Cell. Biochem. 2004; 92: 65-76.
14. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
15. Ayub SG, Ayub T, Khan SN etal. Epidemiological distribution and incidence of different cancers in Kashmir valley-2002-2006. Asian Pac. J. Cancer Prev. 2011; 12: 1867-1872.
16. Rasool S, Ganai BA, Kadla SA etal. The ECRG1 290Arg/Gln polymorphism is related to risk of esophageal squamous cell carcinoma in Kashmir. Asian Pac. J. Cancer Prev. 2011; 12: 265-269.
17. Blessmann M, Pohlenz P, Atac A etal. Single nucleotide polymorphism in esophageal cancer related gene 1: an analysis in resected oral squamous cell carcinoma patients. Int. J. Oral Maxillofac. Surg. 2009; 38: 779-784.
18. Bachmann K, Shahmiri S, Kaifi J etal. Polymorphism Arg290Arg in esophageal-cancer-related gene 1 (ECRG1) is a prognostic factor for survival in esophageal cancer. J. Gastrointest. Surg. 2009; 13: 181-187.
19. Umar M, Upadhyay R, Khurana R, Kumar S, Ghoshal UC, Mittal B. Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer: a case control study in a northern Indian population. Mol. Biol. Rep. 2012; 39: 1153-1162.
20. Upadhyay R, Khurana R, Kumar S, Ghoshal UC, Mittal B. Role of survivin gene promoter polymorphism (-31G>C) in susceptibility and survival of esophageal cancer in northern India. Ann. Surg. Oncol. 2011; 18: 880-887.
21. Jain M, Kumar S, Upadhyay R etal. Influence of apoptosis (BCL2, FAS), cell cycle (CCND1) and growth factor (EGF, EGFR) genetic polymorphisms on survival outcome: an exploratory study in squamous cell esophageal cancer. Cancer Biol. Ther. 2007; 6: 1553-1558.
22. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16: 1215.
23. Gauderman W. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. Available from URL: http://hydra.usc.edu/gxe. 2006.
24. Dupont WD, Plummer WD, Jr. Power and sample size calculations. A review and computer program. Control. Clin. Trials 1990; 11: 116-128.
25. Carlson JM, Heckerman D, Shani G. Estimating false discovery rates for contingency tables. Microsoft Research 2009 May 6.
26. Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003; 31: 3812-3814.
27. Adzhubei IA, Schmidt S, Peshkin L etal. A method and server for predicting damaging missense mutations. Nat. Methods 2010; 7: 248-249.
28. DerSimonian RaL N. Meta-Analysis in Clinical Trials. Control. Clin.l Trials. 1986; 7: 177-188.
29. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl Cancer Inst. 1959; 22: 719-748.
30. Egger M, Smith DJ, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
31. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med. Res. Methodol. 2006; 6: 50.
32. Upadhyay R, Malik MA, Zargar SA, Mittal B. OGG1 Ser326Cys Polymorphism and Susceptibility to Esophageal Cancer in Low and High At-Risk Populations of Northern India. J Gastrointest Cancer 2010; 41: 110-115.
33. Yang X, Xiong G, Chen X etal. Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 2009; 135: 1341-1349.
34. Zhao P, Lin F, Li Z, Lin B, Lin J, Luo R. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and risk of esophageal cancer. Asian Pac. J. Cancer Prev. 2011; 12: 2019-2023.
35. Qin JM, Yang L, Chen B etal. Interaction of methylenetetrahydrofolate reductase C677T, cytochrome P4502E1 polymorphism and environment factors in esophageal cancer in Kazakh population. World J. Gastroenterol. 2008; 14: 6986-6992.
36. Umar M, Upadhyay R, Khurana R, Kumar S, Ghoshal UC, Mittal B. Evaluation of MTHFR677C>T polymorphism in prediction and prognosis of esophageal squamous cell carcinoma: a case-control study in a northern Indian population. Nutr. Cancer 2010; 62: 743-749.
37. Jackson RJ, Engelman RW, Coppola D, Cantor AB, Wharton W, Pledger WJ. p21Cip1 nullizygosity increases tumor metastasis in irradiated mice. Cancer Res. 2003; 63: 3021-3025.
38. Enzinger PC, Mayer RJ. Esophageal cancer. N. Engl. J. Med. 2003; 349: 2241-2252.
39. Ganesh B, Talole SD, Dikshit R. Tobacco, alcohol and tea drinking as risk factors for esophageal cancer: a case-control study from Mumbai, India. Cancer Epidemiol. 2009; 33: 431-434.
40. Moaven O, Raziee HR, Sima HR etal. Interactions between Glutathione-S-Transferase M1, T1 and P1 polymorphisms and smoking, and increased susceptibility to esophageal squamous cell carcinoma. Cancer Epidemiol. 2010; 34: 285-290.